Michelle Sittig

10PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 08, 2022
Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.

Felipe Lopez-Ramirez, Vadim Gushchin, Michelle Sittig

|Sep 21, 2021
Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases.

Andrei Nikiforchin, Vadim Gushchin, Michelle Sittig

|Mar 05, 2021
Educational Collaboration Between Russian-Born US Physicians and Russian Oncology Trainees in Evidence-Based Medicine: The Higher School of Oncology.

Ekaterina Baron, Michelle Sittig, Maxim Kotov

|Feb 01, 2021
Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.

Andrei Nikiforchin, Vadim Gushchin, Mary Caitlin King

|Dec 31, 2020
Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).

Carlos A Munoz-Zuluaga, Armando Sardi, Michelle Sittig

|Dec 28, 2020
Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritonei.

Mary Caitlin King, Carlos Munoz-Zuluaga, Panayotis Ledakis

Pageof 2

Frequent Collaborators

9 joint publications

Armando Sardi

8 joint publications

Vadim Gushchin

5 joint publications

Mary Caitlin King

4 joint publications

Carlos Munoz-Zuluaga